Literature DB >> 30367067

Diagnostic value of signs, symptoms and diagnostic tests for diagnosing pneumonia in ambulant children in developed countries: a systematic review.

Marjolein J C Schot1, Anne R J Dekker2, Wesley G Giorgi3, Rogier M Hopstaken4, Niek J de Wit2, Theo J M Verheij2, Jochen W L Cals3.   

Abstract

Identifying a child with pneumonia in the large group of children with acute respiratory tract infections can be challenging for primary care physicians. Knowledge on the diagnostic value of specific signs and symptoms may guide future decision rules and guidelines for clinicians. We aimed to identify and systematically review available evidence for the diagnostic value of signs, symptoms, and additional tests to diagnose pneumonia in children in an ambulatory setting in developed countries. We conducted a systematic review, searching in the electronic databases of PubMed and Embase. Quality assessment of studies was done using the QUADAS-2 criteria. After data extraction from selected studies, we calculated and summarized test characteristics (sensitivity, specificity, negative and positive predictive values) of all available signs, symptoms, additional laboratory tests, and chest ultrasonography. The original search yielded 4665 records, of which 17 articles were eligible for analysis: 12 studies on signs and symptoms, 4 on additional laboratory tests, and 6 on ultrasonography. All included studies were performed in a secondary care setting. Risk of bias was present in the majority of studies in the domain of patient selection. Prevalence of pneumonia varied from 3.4% to 71.7%. The diagnostic value of the available 27 individual signs and symptoms to identify pneumonia was low. In a low prevalence setting, (4 studies, pneumonia prevalence <10%) clinically ill appearance of the child and oxygen saturation <94% can aid a physician. In a high prevalence setting (10 studies, pneumonia >10%), additional diagnostic tests such as oxygen saturation, C-reactive protein, and white blood cell count are more promising. Chest ultrasonography showed high diagnostic value in settings with higher prevalence of pneumonia. Single signs and symptoms from medical history and physical examination or individual additional diagnostic tests are insufficient to diagnose pneumonia in ambulant children. Very few diagnostic studies are conducted in settings with low prevalence of pneumonia. Future research in low prevalence settings should focus on the diagnostic value of the combination of clinical features and additional testing possibly using meta-analysis of individual data.

Entities:  

Mesh:

Year:  2018        PMID: 30367067      PMCID: PMC6203790          DOI: 10.1038/s41533-018-0104-8

Source DB:  PubMed          Journal:  NPJ Prim Care Respir Med        ISSN: 2055-1010            Impact factor:   2.871


  48 in total

1.  British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011.

Authors:  Michael Harris; Julia Clark; Nicky Coote; Penny Fletcher; Anthony Harnden; Michael McKean; Anne Thomson
Journal:  Thorax       Date:  2011-10       Impact factor: 9.139

2.  The added value of C-reactive protein measurement in diagnosing pneumonia in primary care: a meta-analysis of individual patient data.

Authors:  Margaretha C Minnaard; Joris A H de Groot; Rogier M Hopstaken; Alwin Schierenberg; Niek J de Wit; Johannes B Reitsma; Berna D L Broekhuizen; Saskia F van Vugt; Arie Knuistingh Neven; Aleida W Graffelman; Hasse Melbye; Timothy H Rainer; Johann Steurer; Anette Holm; Ralph Gonzales; Geert-Jan Dinant; Alma C van de Pol; Theo J M Verheij
Journal:  CMAJ       Date:  2016-09-19       Impact factor: 8.262

3.  Do published guidelines predict pneumonia in children presenting to an urban ED?

Authors:  S G Rothrock; S M Green; J M Fanelli; E Cruzen; K A Costanzo; J Pagane
Journal:  Pediatr Emerg Care       Date:  2001-08       Impact factor: 1.454

4.  First-line diagnosis of paediatric pneumonia in emergency: lung ultrasound (LUS) in addition to chest-X-ray (CXR) and its role in follow-up.

Authors:  Stefania Ianniello; Claudia Lucia Piccolo; Grazia L Buquicchio; Margherita Trinci; Vittorio Miele
Journal:  Br J Radiol       Date:  2016-01-22       Impact factor: 3.039

5.  Application of the world health organization criteria to predict radiographic pneumonia in a US-based pediatric emergency department.

Authors:  Sarah L Wingerter; Richard G Bachur; Michael C Monuteaux; Mark I Neuman
Journal:  Pediatr Infect Dis J       Date:  2012-06       Impact factor: 2.129

Review 6.  [Summary of NHG practice guideline 'Acute cough'].

Authors:  Lisette Verlee; Theo J M Verheij; Rogier M Hopstaken; Jan M Prins; Philippe L Salomé; Patrick J E Bindels
Journal:  Ned Tijdschr Geneeskd       Date:  2012

7.  Can we predict which children with clinically suspected pneumonia will have the presence of focal infiltrates on chest radiographs?

Authors:  Tim Lynch; Robert Platt; Serge Gouin; Charles Larson; Yves Patenaude
Journal:  Pediatrics       Date:  2004-03       Impact factor: 7.124

8.  Antibiotic prescribing for children in primary care and adherence to treatment guidelines.

Authors:  Verica Ivanovska; Karin Hek; Aukje K Mantel Teeuwisse; Hubert G M Leufkens; Mark M J Nielen; Liset van Dijk
Journal:  J Antimicrob Chemother       Date:  2016-03-05       Impact factor: 5.790

9.  Antibiotic prescribing in relation to diagnoses and consultation rates in Belgium, the Netherlands and Sweden: use of European quality indicators.

Authors:  Mia Tyrstrup; Alike van der Velden; Sven Engstrom; Geert Goderis; Sigvard Molstad; Theo Verheij; Samuel Coenen; Niels Adriaenssens
Journal:  Scand J Prim Health Care       Date:  2017-03-03       Impact factor: 2.581

10.  Current and future use of point-of-care tests in primary care: an international survey in Australia, Belgium, The Netherlands, the UK and the USA.

Authors:  Jeremy Howick; Jochen W L Cals; Caroline Jones; Christopher P Price; Annette Plüddemann; Carl Heneghan; Marjolein Y Berger; Frank Buntinx; John Hickner; Wilson Pace; Tony Badrick; Ann Van den Bruel; Caroline Laurence; Henk C van Weert; Evie van Severen; Adriana Parrella; Matthew Thompson
Journal:  BMJ Open       Date:  2014-08-08       Impact factor: 2.692

View more
  6 in total

1.  Validation of the British Thoracic Society Severity Criteria for Pediatric Community-acquired Pneumonia.

Authors:  Lilliam Ambroggio; Cole Brokamp; Rachel Mantyla; Bradley DePaoli; Richard M Ruddy; Samir S Shah; Todd A Florin
Journal:  Pediatr Infect Dis J       Date:  2019-09       Impact factor: 2.129

2.  Diagnosing community-acquired pneumonia via a smartphone-based algorithm: a prospective cohort study in primary and acute-care consultations.

Authors:  Paul Porter; Joanna Brisbane; Udantha Abeyratne; Natasha Bear; Javan Wood; Vesa Peltonen; Phillip Della; Claire Smith; Scott Claxton
Journal:  Br J Gen Pract       Date:  2021-03-26       Impact factor: 5.386

3.  Incidence and Risk Factors for Severe Pneumonia in Children Hospitalized with Pneumonia in Ujjain, India.

Authors:  Sunil Kumar Kasundriya; Mamta Dhaneria; Aditya Mathur; Ashish Pathak
Journal:  Int J Environ Res Public Health       Date:  2020-06-27       Impact factor: 3.390

4.  Overdiagnosis paradigm: not suitable for decreasing the overuse of antibiotics.

Authors:  Gloria Cordoba; Carl Llor
Journal:  BMJ Evid Based Med       Date:  2019-02-11

5.  Development and validation of a simple tool composed of items on dyspnea, respiration rates, and C-reactive protein for pneumonia prediction among acute febrile respiratory illness patients in primary care settings.

Authors:  Fengming Ding; Lei Han; Dongning Yin; Yan Zhou; Yong Ji; Pengyu Zhang; Wensheng Wu; Jijing Chen; Zufang Wang; Xinxin Fan; Guoqing Zhang; Min Zhang
Journal:  BMC Med       Date:  2022-10-18       Impact factor: 11.150

6.  Electronic personal protective equipment: A strategy to protect emergency department providers in the age of COVID-19.

Authors:  Robert W Turer; Ian Jones; S Trent Rosenbloom; Corey Slovis; Michael J Ward
Journal:  J Am Med Inform Assoc       Date:  2020-06-01       Impact factor: 4.497

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.